Tumor Imaging: From Screening to Response Assessment
Tumor Imaging: From Screening to Response Assessment is organized by American Roentgen Ray Society (ARRS).
Expiration Date: June 19, 2032
Description:
This course delivers the latest imaging information concerning lung, colorectal, and breast cancer. Participants will gain the interpretive, technical, and systems knowledge radiologists need to provide quality screening, while learning strategies to address overall care disparities. Providing a truly comprehensive review of oncologic imaging, additional discussions will address diagnostic workflows, enterprise solutions, new horizons in PET/MRI, and the role of AI. Response assessment criteria, including RECIST 1.1, iRECIST, and Lugano, as well as business models for establishing a response assessment lab, will also be discussed.
Learning Outcomes and Modules
After completing this course, the learner should be able to:
• Describe techniques for optimal performance and interpretation of lung cancer screening examinations
• Discuss optimal technique for performance and interpretation of CT colonography examinations for colorectal cancer screening
• Describe the latest developments in breast cancer screening, including abbreviated MRI protocols and contrast-enhanced mammography
• Explain various response assessment criteria for solid organ tumors, including RECIST 1.1, iRECIST, and Lugano
• Discuss disparities in cancer screening and strategies to address disparities